You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Boehringer Ingelheim
Baxter
Dow
Harvard Business School

Last Updated: October 23, 2020

DrugPatentWatch Database Preview

Hydroxyurea - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Prices for hydroxyurea

See drug prices for hydroxyurea

Recent Clinical Trials for hydroxyurea

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Phoenicia BioSciencePhase 1/Phase 2
National Heart, Lung, and Blood Institute (NHLBI)Phase 1/Phase 2
Iqvia Pty LtdPhase 3

See all hydroxyurea clinical trials

Pharmacology for hydroxyurea
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for hydroxyurea

US Patents and Regulatory Information for hydroxyurea

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-001 Jul 30, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Leading Pharma Llc HYDROXYUREA hydroxyurea CAPSULE;ORAL 213438-001 Apr 8, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb DROXIA hydroxyurea CAPSULE;ORAL 016295-002 Feb 25, 1998 RX Yes No   Start Trial   Start Trial   Start Trial
Roxane HYDROXYUREA hydroxyurea CAPSULE;ORAL 074476-001 Aug 18, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb HYDREA hydroxyurea CAPSULE;ORAL 016295-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Par Pharm HYDROXYUREA hydroxyurea CAPSULE;ORAL 075340-001 Feb 24, 1999 AB RX No No   Start Trial   Start Trial   Start Trial
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-002 Jun 26, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
McKinsey
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.